NIH and VC Funding; Growth Engines for the Life Science Industry; Exploring Similarities, Differences, and Overall Objectives. A panel discussion at the 14th Annual Non-Dilutive Funding Summit featuring: Ram May-Ron, Managing Partner, FreeMind Group | B. Christopher Kim, Managing Partner, Novatio Ventures | Dr. Matthew Portnoy, Director, Division of Special Programs – Office of Extramural […]
Tyler G. Merkeley, MS, MBA, PMP, Interim Director, DRIVe (Division of Research, Innovation, and Ventures), presents: From CARB-X to DRIVe: How We Are Building Novel Public Private Partnership with Non-Dilutive Funding to Foster Disruptive Innovation to Enhance National Health Security at the 14th Annual Non-Dilutive Funding Summit. View slide deck
Dr. Matthew E. Portnoy, Ph.D., Director, Division of Special Programs, NIH SBIR/STTR Program Manager, Office of Extramural Programs, Office of Extramural Research, NIH, presents: A Discussion with Matt Portnoy, Head of a $1B Government Seed Fund at the 14th Annual Non-Dilutive Funding Summit. View slide deck
Dr. Todd Haim, Ph.D., Chief of the Office of Small Business Research at National Institute on Aging (NIA), describes the NIA SBIR/STTR programs, funding opportunities, and application tips from NIH program officers at the 14th Annual Non-Dilutive Funding Summit. View slide deck
Christine Densmore, M.S., Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) talks about SBIR/STTR and the NIDDK: Overview and R&D Interests at the 14th Annual Non-Dilutive Funding Summit. View slide deck
Debkishore Mitra, PhD., Co-Founder and Chief Technological Officer, Diassess, shares his experience on Diassess’s successful non-dilutive funding journey at the 14th Annual Non-Dilutive Funding Summit. View slide deck
Dr Dana Larocca, Vice President of Discovery Research, AgeX Inc. shares her story on how AgeX obtained Initial non-dilutive funding for their programs at the 14th Annual Non-Dilutive Funding Summit. View slide deck
The Congressionally Directed Medical Research Programs (CDMRP), are supported by funds allocated by Congress for biomedical research in response to the needs of the American people and military. With a FY2018 budget of over $975 million, these funds will go towards supporting R&D efforts in various stages of development. Some research areas covered include Breast […]
NIH alone awards roughly $6B annually to Cancer related R&D grants and contracts. The scope of funding support covers much of the R&D cycle, from basic research, through pre-clinical activities and early phase clinical trials. In this webinar, we discuss key cancer related opportunities, focusing on the new set of solicitations from the National […]